Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026)
Qt Imaging Holdings (QTI) reported Net Income towards Common Stockholders of -$3.4 million for Q1 2026, up 69.41% year-over-year from -$2.0 million in Q1 2025, and down 145.38% quarter-over-quarter from -$1.4 million in Q4 2025.
Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$3.4 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$3.4 million, up 69.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.4 million (up 45.89% YoY), and the FY2025 annual result was -$21.1 million, down 48.78% from the prior year.
- Net Income towards Common Stockholders retreated to -$3.4 million in Q1 2026 per QTI's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$382333.0 in Q1 2022 and troughed at -$11.1 million in Q1 2025.
- A 5-year average of -$3.1 million and a median of -$1.8 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2026: Net Income towards Common Stockholders tumbled 969.49% in 2022, then surged 69.41% in 2026.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.6 million in 2022, then gained by 6.44% to -$1.5 million in 2023, then tumbled by 131.02% to -$3.5 million in 2024, then soared by 60.21% to -$1.4 million in 2025, then tumbled by 145.38% to -$3.4 million in 2026.
- Business Quant data shows QTI's Net Income towards Common Stockholders at -$3.4 million in Q1 2026, -$1.4 million in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Qt Imaging Holdings | 55.74 Mn | 55.74 Mn | 2.67 Mn | -3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.41 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -11.14 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.33 Mn |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | -1.61 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -846,652.00 |
| Mar 31, 2022 | -382,333.00 |
| Dec 31, 2021 | -871,859.00 |
| Sep 30, 2021 | -204,317.00 |
| Mar 31, 2021 | -35,749.00 |